Skip to main content
Article thumbnail
Location of Repository

The physiological role of peroxiredoxin 2 in human erythrocytes: a kinetic analysis

By Rui Manuel Vicente Benfeitas


Tese de mestrado em Bioquímica, apresentada à Universidade de Lisboa, através da Faculdade de Ciências, 2011Peroxiredoxin 2 (Prx2) is a hydrogen peroxide reducing protein abundant in human erythrocytes. Due to its large concentration (3.7×10-4 M) and high reactivity with hydrogen peroxide (k~108 M-1s-1) it is a potentially very relevant antioxidant for the defense of erythrocytes against hydrogen peroxide. However, its contribution for H2O2 defense is not clear. The antioxidant activity of Prx2 is affected by the limited capacity that erythrocytes have for reducing Prx2 to its active form after it is oxidized by hydrogen peroxide. Further, human erythrocytes also possess catalase, an H2O2 scavenger whose antioxidant activity entails minimal NADPH consumption. In contrast, Prx2-mediated H2O2 reduction is stoichiometrically coupled to NADPH oxidation. Why do then erythrocytes need Prx2? Why do they not rely only on catalase, the H2O2 scavenger whose activity requires less NADPH? Is Prx2 redundant for H2O2 defense in human erythrocytes? We used kinetic analyses and mathematical modeling to clarify these issues. We considered the main processes protecting human erythrocytes against H2O2: glutathione peroxidase (GPx1), catalase and Prx2. The analysis of the dynamic behavior of the Prx2 system under various oxidative conditions indicates the following. Basal oxidative conditions, assuming a sustained extracellular H2O2 (eH2O2) concentration <10-7 M or intracellular H2O2 (iH2O2) concentration <2×10-11 M allow Prx2 to remain fully reduced. Prx2 then consumes more than 99% of the iH2O2. On the other hand, catalase becomes the main defense against H2O2 in erythrocytes facing sustained exposure to loads that fully oxidize Prx2 (eH2O2> 1.4×10-6 M). Catalase and GPx1 then contribute for 84% and 16% of the H2O2 consumption, respectively. Even when Prx2 is fully oxidized, eH2O2 consumption by erythrocytes is limited by membrane permeation. Thus, although erythrocytes are quite likely the main sink of plasma H2O2, Prx2 is dispensable for this role. Despite the slow Prx2 regeneration under strong oxidative loads, our analyses also suggest that erythrocytes could not rely solely on catalase and Gpx1 for defense against H2O2. To fully replace Prx2, maintaining the same H2O2 concentration and response time as in normal erythrocytes, ~11×10-12 g catalase (6×10-12 g GPx1) would be required. This would amount to 32% (18 %) of the hemoglobin in human erythrocytes. Such a solution could therefore impair oxygen transport either by making erythrocytes bigger, and thus less able to cross capillaries, or by reducing the space available for hemoglobin. On the other hand, a <1 % increase in Prx2 concentration would suffice to compensate for the effect of catalase elimination on H2O2 concentration and response time at basal oxidative loads. These differences are due to the much higher specific activity of Prx2. Our analyses also suggest that crossing of inflammation sites may lead to substantial but brief Prx2 oxidation. The residence time of a circulating erythrocyte in an inflammation site is determined by the time (~2 s) to cross the capillaries, where these cells are in most intimate contact with the vasculature walls and circulate most slowly. Full Prx2 oxidation occurs if those inflammation foci lead to > 25×10-6 M H2O2 in the plasma, which is in the scale of the strongest loads experimentally determined for inflammatory foci in other organisms. Once all Prx2 is oxidized, erythrocytes can regenerate the reduced form in minutes if the oxidative load returns to basal values. However, a stepwise increase in Prx2 oxidation through repeated crossing of inflammation sites is very unlikely. This because such crossings are expected to occur many hours in between, time enough for Prx2 to be fully reduced. Altogether, our results show that Prx2 is the main defense of human erythrocytes against H2O2 under most physiological circumstances. Extensive Prx2 oxidation may be attained in inflammation sites, affecting its contribution for H2O2 consumption. Yet, this does not impair the erythrocytes’ ability to scavenge plasma H2O2 because they can still rely on catalase for the defense against H2O2. Our results have important implications for the study of antioxidant protection and reactive oxygen species-associated diseases in mammalian cells, where Prx2 and catalase are found

Topics: Bioquímica, Teses de mestrado - 2011
Year: 2011
OAI identifier:

Suggested articles


  1. (2002). A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. doi
  2. (1992). A mechanism for NADPH inhibition of catalase compound II formation. doi
  3. (1974). A multiple wavelength analysis of the reaction between hydrogen peroxide and metmyoglobin. doi
  4. (1900). A New Enzyme of General Occurrence in Organisms. doi
  5. (1990). A novel antioxidant role for hemoglobin. The comproportionation of ferrylhemoglobin with oxyhemoglobin.
  6. (1997). A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. doi
  7. (2009). A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. doi
  8. (1996). Activated oxygen species in the oxidation of glutathione A kinetic study. doi
  9. (1965). Activity of catalase in the red cell. doi
  10. (2001). Alkyl hydroperoxide reductase is the primary scavenger of endogenous hydrogen peroxide in Escherichia coli. doi
  11. (2006). Amazing numbers in biology. doi
  12. (1989). An alkyl hydroperoxide reductase from Salmonella typhimurium involved in the defense of DNA against oxidative damage. Purification and properties.
  13. (1983). An automatic image analysis study of the microcirculation in inflammation. doi
  14. (1974). An improved coupled test procedure for glutathione peroxidase (EC 1-11-1-9-) in blood. doi
  15. (1988). Antioxidant defenses and lipid peroxidation in human blood plasma. doi
  16. (2009). Assessment of inactive, active and mixed atherosclerotic plaques by 18F-FDG-PET; an age group-based correlation with cardiovascular risk factors. doi
  17. (2003). ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. doi
  18. (2003). Autoimmunity: busting the atherosclerotic plaque. doi
  19. (1961). Biochemical aspects of phagocytosis. doi
  20. (1996). Capillary blood cell velocity in human skin capillaries located perpendicularly to the skin surface: measured by a new laser Doppler anemometer. doi
  21. (1977). Capillary lengths, anastomoses, and estimated capillary transit times in skeletal muscle.
  22. (2007). Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. doi
  23. (1989). Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes.
  24. (1984). Catalase in vitro. doi
  25. (1984). Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH. doi
  26. (2003). Catalytic mechanism of thiol peroxidase from Escherichia coli. Sulfenic acid formation and overoxidation of essential CYS61. doi
  27. (1986). Cell flow path influences transit time through striated muscle capillaries.
  28. (2006). Characterization of acatalasemic erythrocytes treated with low and high dose hydrogen peroxide. Hemolysis and aggregation. doi
  29. (2006). Characterization of alternative cytosolic forms and cellular targets of mouse mitochondrial thioredoxin reductase. doi
  30. (2004). Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. doi
  31. (1987). Characterization of the hydroperoxidereducing activity of human plasma. doi
  32. (1987). Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase.
  33. (1994). Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. doi
  34. (1993). Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae.
  35. (1997). Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. doi
  36. (2006). Compensatory functions of two alkyl hydroperoxide reductases in the oxidative defense system of Legionella pneumophila. doi
  37. (2000). Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7 A resolution. doi
  38. (2004). Cytosolic thioredoxin peroxidase I and II are important defenses of yeast against organic hydroperoxide insult: catalases and peroxiredoxins cooperate in the decomposition of H2O2 by yeast. doi
  39. (1997). Determination of catalase activity at physiological hydrogen peroxide concentrations. doi
  40. (1997). Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. doi
  41. (1979). Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages.
  42. (1978). Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. doi
  43. (1997). Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes.
  44. (1985). Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking. doi
  45. (1960). Electron micrographic observations on the emigration of leucocytes.
  46. (1996). EPR evidence for a tyrosyl radical intermediate in bovine liver catalase. doi
  47. (1997). EPR investigation of compound I in Proteus mirabilis and bovine liver catalases: formation of porphyrin and tyrosyl radical intermediates. doi
  48. (1991). Erythrocyte defense against hydrogen peroxide: preeminent importance of catalase.
  49. (2003). Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. doi
  50. (2004). Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
  51. (2005). Fluorescence probes used for detection of reactive oxygen species. doi
  52. (2000). Formation of homovanillic acid dimer by enzymatic or Fenton system - catalyzed oxidation. doi
  53. (1985). Free-radical production and oxidative reactions of hemoglobin. doi
  54. (1964). Generation of Hydrogen Peroxide in Erythrocytes by Hemolytic Agents. doi
  55. (1984). Generation of superoxide ion in human red blood cell lysates. doi
  56. (1973). Generation of superoxide radicals during the autoxidation of mammalian oxyhemoglobin. doi
  57. (2007). Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a genderspecific manner (the SELGEN study). doi
  58. (2006). Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. doi
  59. (2003). Global analysis of protein expression in yeast. doi
  60. (1977). Glucose-6-phosphate dehydrogenase deficiency and red cell glutathione peroxidase. doi
  61. (1972). Glutathione peroxidase, V. The kinetic mechanism. doi
  62. (1978). Glutathione peroxidase: fact and fiction. Ciba Found Symp,
  63. (1963). Glutathione peroxidase: The primary agent for the elimination of hydrogen peroxide in erythrocytes. doi
  64. (1984). Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. doi
  65. (1976). Glutathione reductase from human erythrocytes. Catalytic properties and aggregation. doi
  66. (1987). Glutathione regeneration in density-fractionated human erythrocytes.
  67. (2005). Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. doi
  68. (1957). Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown.
  69. (1986). Hemoglobin: molecular, genetic and clinical aspects (WB Saunders Co.
  70. (1996). Human body composition (Human Kinetics
  71. (1972). Human erythrocyte catalase: an improved method of isolation and a reevaluation of reported properties. doi
  72. (1978). Human erythrocyte glucose 6-phosphate dehydrogenase: structure and function in normal and mutant subjects.
  73. (1987). Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical. doi
  74. (2001). Hydrogen peroxide and superoxide anion production by polymorphonuclear neutrophils in patients with chronic periapical granuloma, before and after surgical treatment. doi
  75. (1991). Hydrogen peroxide in human blood. doi
  76. (1981). Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. doi
  77. (1994). Hydrogen peroxide production by red blood cells. doi
  78. (1979). Hydroperoxide metabolism in mammalian organs. doi
  79. (2005). Hypoxia-induced post-translational changes in red blood cell protein map of newborns. doi
  80. (1994). Importance of catalase in the disposal of hydrogen peroxide within human erythrocytes.
  81. (1972). Improved measurements of the erythrocyte geometry. doi
  82. (2010). In vitro studies with 'acatalasemic-like' erythrocytes and hydrogen peroxide: attention to the formation of lysis resistant erythrocytes. doi
  83. (2002). Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. doi
  84. (1989). Induction of an antioxidant protein of Saccharomyces cerevisiae by O2, Fe3+, or 2-mercaptoethanol. doi
  85. (2005). Inhibitory role of peroxiredoxin II (Prx II) on cellular senescence. doi
  86. (1973). Interaction of haemoglobin with ions. Quantitative description of the state of magnesium, adenosine 5'-triphosphate, 2,3-bisphosphoglycerate, and human haemoglobin under simulated intracellular conditions. doi
  87. (2000). Interaction of human thiol-specific antioxidant protein 1 with erythrocyte plasma membrane. doi
  88. (1974). Intracellular restraint: a new basis for the limitation in response to oxidative stress in human erythrocytes containing low-activity variants of glucose-6-phosphate dehydrogenase. doi
  89. (2010). Irreversible inactivation of glutathione peroxidase 1 and reversible inactivation of peroxiredoxin II by H2O2 in red blood cells. doi
  90. (2001). Isolation and characterization of a new peroxiredoxin from poplar sieve tubes that uses either glutaredoxin or thioredoxin as a proton donor. doi
  91. (2001). Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. doi
  92. (2009). Linkage of cytosolic peroxiredoxin 2 to erythrocyte membrane imposed by hydrogen peroxide-induced oxidative stress. doi
  93. (2005). Localization, annotation, and comparison of the Escherichia coli K-12 proteome under two states of growth. doi
  94. (1977). Low-pressure solubility of gases in liquid water. doi
  95. (2008). Mathematica, Version 7.0 edn
  96. (1995). Mechanism and structure of thioredoxin reductase from Escherichia coli. doi
  97. (1971). Mechanism of the hydrogen peroxide hemolysis test and its reversal with phenols.
  98. (1999). Mechanisms of protection of catalase by NADPH. Kinetics and stoichiometry. doi
  99. (1995). Metabolic sources of hydrogen peroxide in aerobically growing Escherichia coli. doi
  100. (1997). Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. doi
  101. (2004). Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. doi
  102. (2000). Modulation of the activities of catalase-peroxidase HPI of Escherichia coli by site-directed mutagenesis. doi
  103. (1986). NADP-binding proteins causing reduced availability and sigmoid release of NADP+ in human erythrocytes.
  104. (1994). NADPH binding and control of catalase compound II formation: comparison of bovine, yeast, and Escherichia coli enzymes.
  105. (1996). Negative association between erythrocyte reduced glutathione concentration and diabetic complications.
  106. (1985). Nonenzymatic cleavage of proteins by reactive oxygen species generated by dithiothreitol and iron.
  107. (2000). Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. doi
  108. (2004). Only a small subset of the horizontally transferred chromosomal genes in Escherichia coli are translated into proteins. doi
  109. (1964). Osmotic properties of human red cells. doi
  110. (2002). Oxidation of glutathione peroxidase-deficient red cells by organic peroxides. doi
  111. (2003). Oxidation of nuclear thioredoxin during oxidative stress. doi
  112. (2005). Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death. doi
  113. (2002). Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. doi
  114. (2007). Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. doi
  115. (2003). Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice.
  116. (2007). Peroxiredoxin-2 links Cdk5 to neurodegeneration. doi
  117. (1984). Physiology of the human body (Saunders College
  118. (1998). Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. doi
  119. (1989). Plasma selenium-dependent glutathione peroxidase. Cell of origin and secretion.
  120. (1996). Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes.
  121. (1991). Production of large amounts of hydrogen peroxide by human tumor cells.
  122. (1970). Properties and regulation of glutathione peroxidase. doi
  123. (1987). Proteins damaged by oxygen radicals are rapidly degraded in extracts of red blood cells.
  124. (2008). Proteomic analysis of heat-stable proteins in Escherichia coli. doi
  125. (1994). Purification and characterization of thiol-specific antioxidant protein from human red blood cell: a new type of antioxidant protein. doi
  126. (1990). Purification and measurement of calpromotin, the cytoplasmic protein which activates calcium-dependent potassium transport. doi
  127. (1975). Purification and properties of human erythrocyte glutathione peroxidase.
  128. (1999). Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. doi
  129. (1991). Reconstitution of Ca(2+)-dependent K+ transport in erythrocyte membrane vesicles requires a cytoplasmic protein.
  130. (1984). Red cell metabolism : a manual of biochemical methods, 3rd edn
  131. (1975). Red cell NADP+ and NADPH in glucose-6-phosphate dehydrogenase deficiency. doi
  132. (2000). Red cells from glutathione peroxidase-1-deficient mice have nearly normal defenses against exogenous peroxides.
  133. (2002). Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. doi
  134. (2009). Redox control of the cell cycle in health and disease. doi
  135. (2005). Redox-dependent transcriptional regulation.
  136. (2007). Reduction of 1-Cys peroxiredoxins by ascorbate changes the thiol-specific antioxidant paradigm, revealing another function of vitamin C. doi
  137. (2009). Redundant hydrogen peroxide scavengers contribute to Salmonella virulence and oxidative stress resistance. doi
  138. (1999). Refinement and evaluation of a model of Mg2+ buffering in human red cells. doi
  139. (1986). Regulation of glucose-6-phosphate dehydrogenase in human erythrocytes. doi
  140. (1985). Regulation of the human-erythrocyte hexosemonophosphate shunt under conditions of oxidative stress. A study using NMR spectroscopy, a kinetic isotope effect, a reconstituted system and computer simulation. doi
  141. (1981). Role of cell-generated hydrogen peroxide in granulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro. doi
  142. (1997). RpoS- and OxyR-independent induction of HPI catalase at stationary phase in Escherichia coli and identification of rpoS mutations in common laboratory strains.
  143. (2007). Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1. doi
  144. (1994). Single extraction method for the spectrophotometric quantification of oxidized and reduced pyridine nucleotides in erythrocytes. doi
  145. (1958). Stimulation of the glucose oxidative pathway in human erythrocytes by methylene blue.
  146. (1997). Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. doi
  147. (2003). Structure, mechanism and regulation of peroxiredoxins. doi
  148. (1984). Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. doi
  149. (1967). Studies on the chemistry of hemoglobin. I. The reactive sulfhydryl groups.
  150. (1960). Studies on vitamin E. 5. Lipid peroxidation in dialuric acid-induced haemolysis of vitamin E-deficient erythrocytes.
  151. (1994). The cDNA sequence for calpromotin indicates that it plays a significant role in the proliferation and differentiation of hematopoietic-cells.
  152. (2010). The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. doi
  153. (1964). The Formation and Catalytic Role of Catalase Peroxide Compound Ii. doi
  154. (1987). The function of catalase-bound NADPH. doi
  155. (1972). The generation of superoxide radical during the autoxidation of hemoglobin.
  156. (1997). The globin-based free radical of ferryl hemoglobin is detected in normal human blood. doi
  157. (2007). The high reactivity of peroxiredoxin 2 with H(2)O(2) is not reflected in its reaction with other oxidants and thiol reagents. doi
  158. (1999). The identification of primary sites of superoxide and hydrogen peroxide formation in the aerobic respiratory chain and sulfite reductase complex of Escherichia coli. doi
  159. (1971). The influence of pH and methylene blue on the pathways of glucose utilization and lactate formation in erythrocytes of man. doi
  160. (1988). The isolation and purification of a specific &quot;protector&quot; protein which inhibits enzyme inactivation by a thiol/Fe(III)/O2 mixed-function oxidation system.
  161. (1973). The levels of superoxide dismutase and catalase in human tissues as determined immunochemically. doi
  162. (1952). The mechanism of catalase action. I. Steady-state analysis. doi
  163. (1963). The mechanism of metmyoglobin oxidation.
  164. (1997). The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. doi
  165. (2009). The peroxidase and peroxynitrite reductase activity of human erythrocyte peroxiredoxin 2. doi
  166. (1977). The Protein Data Bank: a computerbased archival file for macromolecular structures. doi
  167. (1959). The purification and properties of glutathione peroxidase of erythrocytes.
  168. (1989). The scopoletin assay for hydrogen peroxide. A review and a better method. doi
  169. (1994). The thiol-specific antioxidant protein from human brain: gene cloning and analysis of conserved cysteine regions. doi
  170. (2002). Thiol oxidase activity of copper, zinc superoxide dismutase. doi
  171. (1994). Thioredoxin-dependent peroxide reductase from yeast. doi
  172. (1995). Thioredoxin-linked peroxidase from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell. doi
  173. (1981). Thioredoxin, glutaredoxin, and thioredoxin reductase from cultured HeLa cells. doi
  174. (1877). Thrombose und Embolie: Vorlesung über allgemeine Pathologie. doi
  175. (1978). Tissue distrubution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. doi
  176. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. doi
  177. (1995). Transient adaptation to oxidative stress in yeast. doi
  178. (1964). Transport of oxygen and carbon dioxide. doi
  179. (2006). Truncated mutants of human thioredoxin reductase 1 do not exhibit glutathione reductase activity. doi
  180. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
  181. (2004). Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function.
  182. (2001). Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. doi
  183. (2008). Vander's human physiology (McGraw-Hill Higher Education).
  184. (1995). Variability in glutathione-dependent detoxication in vivo and its relevance to detoxication of chemical mixtures. doi
  185. (2001). Variants of peroxiredoxins expression in response to hydroperoxide stress. doi
  186. (2006). Wound healing: an overview. Plast Reconstr Surg 117, doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.